About FDA
Total number of Congressional requests received in the month
Dictionary: The Office of the Center Director (OCD) is responsible for answering the Congress’s questions about the work done by CTP. Congressional correspondences include: general information requests, constituent related requests, letters expressing concerns from Congress, questions for the record related to hearings, briefing requests, and document requests. OCD’s goal is to respond to all Congressional and letter correspondence in a timely manner. OCD and the Office of Legislation established a Memorandum of Understanding (MOU) that outlines targets for responding to Congressional requests and inquiries.
Fiscal Year - 2011
| Time | Target | Number |
|---|---|---|
| Oct 2010 | N/A | 3 |
| Nov 2010 | N/A | 2 |
| Dec 2010 | N/A | 0 |
| Jan 2011 | N/A | 0 |
| Feb 2011 | N/A | 3 |
| Mar 2011 | N/A | 4 |
| Apr 2011 | N/A | 4 |
| May 2011 | N/A | 0 |
| Jun 2011 | N/A | 0 |
| Jul 2011 | N/A | 1 |
| Aug 2011 | N/A | 2 |
| Sep 2011 | N/A | 2 |
FY 2011 Total: 25
Total number of Congressional correspondence received in the month
Fiscal Year - 2011
| Time | Target | Number |
|---|---|---|
| Oct 2010 | N/A | 1 |
| Nov 2010 | N/A | 1 |
| Dec 2010 | N/A | 0 |
| Jan 2011 | N/A | 0 |
| Feb 2011 | N/A | 3 |
| Mar 2011 | N/A | 3 |
| Apr 2011 | N/A | 4 |
| May 2011 | N/A | 0 |
| Jun 2011 | N/A | 0 |
| Jul 2011 | N/A | 0 |
| Aug 2011 | N/A | 2 |
| Sep 2011 | N/A | 2 |
FY 2011 Total: 16
Total number of Congressional briefing requests received in the month
Fiscal Year - 2011
| Time | Target | Number |
|---|---|---|
| Oct 2010 | N/A | 2 |
| Nov 2010 | N/A | 1 |
| Dec 2010 | N/A | 0 |
| Jan 2011 | N/A | 0 |
| Feb 2011 | N/A | 0 |
| Mar 2011 | N/A | 1 |
| Apr 2011 | N/A | 3 |
| May 2011 | N/A | 0 |
| Jun 2011 | N/A | 1 |
| Jul 2011 | N/A | 1 |
| Aug 2011 | N/A | 0 |
| Sep 2011 | N/A | 0 |
FY 2011 Total: 9
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.
